Clinical trials: Atrial Fibrillation New Onset
Obstructive Sleep Apnea, Cardiovascular Diseases
Obstructive Sleep Apnoea and Cardiac Arrhythmias
This study is a prevelance trial looking at how sleep apnoea affects the heart especially heart rhythms. Previous research shows that patients suffering from sleep apnoea are much more likely to get heart disease and abnormal…
- Conditions
- Obstructive Sleep Apnea, Cardiovascular Diseases, Arrhythmia, Atrial Fibrillation New Onset
- Trial name
- OSCA (NCT03866148)
- Testing
- Reveal LINQ
- Where
- United Kingdom
- Volunteers
- 200 people
- Sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
Atrial Fibrillation New Onset, Myocardial Infarction
Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation
After a myocardial infarction (MI), patients discharged home in sinus rhythm may develop AF that is asymptomatic, undetected, and undertreated.
- Trial name
- SIMPL-AF (NCT03345615)
- Testing
- 30-day ambulatory cardiac event monitor
- Where
- Canada
- Volunteers
- 240 people
- Sponsor
- University of British Columbia
Colorectal Cancer, Atrial Fibrillation New Onset
Atrial Fibrillation After Surgery for Colorectal Cancer
This study will report the incidence of atrial fibrillation after elective colorectal cancer resection in the over 65 age group.
- Trial name
- AFAR (NCT04037319)
- Testing
- 24 Hour Holter Monitor
- Where
- United Kingdom
- Volunteers
- 720 people
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
Coronary Artery Disease, Atrial Fibrillation New Onset
Predictors of Postoperative Atrial Fibrillation After CABG
This observational study aims to identify the determinants or predictors of postoperative atrial fibrillation (POAF) in patients who have undergone coronary artery bypass grafting (CABG).
- Trial name
- CODA-AF (NCT05888168)
- Testing
- CABG
- Where
- China
- Volunteers
- 15,000 people
- Sponsor
- Kun Hua
Atrial Fibrillation New Onset, Magnesium Deficiency
Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments
Every day, doctors and nurses make hundreds of decisions about treatments - like when to start or stop them, or how frequently to give them.
- Trial name
- PROSPECTOR (NCT05149820)
- Testing
- Electronic Point of Care Randomisation tool, Magnesium
- Where
- United Kingdom
- Volunteers
- 100 people
- Sponsor
- University College, London
Atrial Fibrillation New Onset, Embolic Stroke of Undetermined Source
PFO Occlusion and Atrial Fibrillation
Interventional closure of patent foramen ovale (PFO) associates with reduced risk of stroke recurrence in patients with cryptogenic ischemic stroke as reported in the recent CLOSE and REDUCE trials.
- Conditions
- Atrial Fibrillation New Onset, Embolic Stroke of Undetermined Source, Patent Foramen Ovale
- Trial name
- NCT04898361
- Testing
- PFO closure
- Where
- Germany
- Volunteers
- 50 people
- Sponsor
- University Hospital, Saarland
Patent Foramen Ovale, Stroke, Cryptogenic
PFO tRanscatether Occlusion Long-term Outcomes National Group (PROLONG) Registry
Patent foramen ovale (PFO) has been associated with cryptogenic stroke and transient ischemic attack (TIA) in young adults. Evidence from randomized clinical trials (RCT) has shown that transcatheter PFO closure yields a 59%…
- Conditions
- Patent Foramen Ovale, Stroke, Cryptogenic, Transient Ischaemic Attack Due to Embolism, Atrial Fibrillation New Onset
- Trial name
- PROLONG (NCT06504121)
- Testing
- Septal Occluder Device
- Volunteers
- 1,360 people
- Sponsor
- IRCCS Ospedale San Raffaele
New Onset, Atrial Fibrillation
Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery
Recently, dexmedetomidine has been suggested as an alternative agent for sedation in tachyarrhythmias due to its antiarrhythmic properties through decreased catecholamine release, prolonged refractory period, and increased vagal…
- Trial name
- NCT07482540
- Testing
- Dexmedetomidine, Saline
- Volunteers
- 140 people
- Sponsor
- Ain Shams University
Atrial Fibrillation, Coronary Artery Disease
Management of New-Onset Postoperative Atrial Fibrillation
One common occurrence following open heart surgery is an irregular rhythm from the top chambers of the heart known as atrial fibrillation (afib or AF).
- Conditions
- Atrial Fibrillation, Coronary Artery Disease, Post Operative Arrythmia
- Trial name
- Monitor-AF (NCT01395836)
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- Emory University
Atrial Fibrillation, Shock
Assessment of the Link Between Monomeric Functional Form Plasma Level of Vasostatin-1 and Occurrence of New Onset Atrial Fibrillation in Severe Intensive Care Patients
Atrial fibrillation (AF) is a cardiac rhythm disorder particularly common in intensive care patients. Some meta-analyzes report a prevalence of new onset AF ranging from 4.5% to 29.5% in polyvalent intensive care.
- Trial name
- TVASORYTHM (NCT03457155)
- Testing
- VS-I dosing in plasma samples
- Where
- France
- Volunteers
- 150 people
- Sponsor
- University Hospital, Strasbourg, France
Atrial Fibrillation
Magnesium Sulphate for Treatment of New Onset Atrial Fibrillation in Medical Intensive Care Unit Patient
The purpose of this study is to determine the efficacy of Magnesium sulphate for the rate and rhythm control of the new onset (within 48 hours) atrial fibrillation in the hemodynamically unstable patients, admitted in the medical…
- Trial name
- EMSAF (NCT01049464)
- Testing
- Magnesium sulphate
- Where
- Thailand
- Volunteers
- 128 people
- Sponsor
- Mahidol University
Atrial Fibrillation New Onset
Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
Rationale Atrial fibrillation (AF) often occurs transiently in the setting of an acute stressor (e.g. medical illness or surgery).
- Trial name
- AFOTS (NCT03221777)
- Testing
- 14 Day ECG Patch (Zio XT Patch, iRhythm Technologies)
- Where
- 3 sites in Canada
- Volunteers
- 281 people
- Sponsor
- Population Health Research Institute
Atrial Fibrillation New Onset
Evaluation Of New Onset Postoperative Atrial Fibrillation
This is a multi-center, prospective, randomized and controlled clinical trial comparing the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation…
- Trial name
- NCT01247974
- Testing
- CorMatrix ECM for Pericardial Closure
- Where
- 16 sites in United States
- Volunteers
- 439 people
- Sponsor
- Elutia Inc.
Atrial Fibrillation New Onset
Stellate Ganglion to Prevent Atrial Fibrillation
New onset atrial fibrillation is a common problem after cardiac surgery. The reported incidence after coronary artery bypass grafting (CABG) is 15-40%, 37-50% after valve surgery, and up to 60% after CABG and valve surgery.
- Trial name
- NCT05656170
- Testing
- Stellate ganglion block, Bupivacain, Saline
- Sponsor
- Rush University Medical Center
Atrial Fibrillation, Hypertension
Effect of Vit D on New-onset AF in Hypertension
Atrial fibrillation (AF), an important cause of cardiac mortality and morbidity is the most common type of cardiac arrhythmia in clinical practice.
- Trial name
- NCT02298738
- Volunteers
- 227 people
- Sponsor
- Ankara University
Atrial Fibrillation, Septic Shock
Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic Shock
Retrospective two-cohort study to determine the effect of chronic antihypertensive therapy on new onset atrial fibrillation and clinical outcomes in septic shock.
- Trial name
- NCT02876341
- Where
- United States
- Volunteers
- 133 people
- Sponsor
- Rush University Medical Center
Atrial Fibrillation New Onset, Atrial Fibrillation Paroxysmal
Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation
Adult patients who are diagnosed new onset atrial fibrillation with rapid ventricular response within 7 days after non-cardiac non-thoracic surgery are enrolled.
- Trial name
- NCT05950971
- Testing
- Amiodarone, diltiazem or esmolol
- Where
- South Korea
- Volunteers
- 1 people
- Sponsor
- Seoul National University Hospital
Atrial Fibrillation
Safety and Efficacy Study of Amniotic Membrane Patch to Treat Postoperative Atrial Fibrillation
The purpose of this study is to to evaluate the rate of new onset postoperative atrial fibrillation in subjects receiving the amniotic membrane patch placed on the epicardial surface as compared to subjects who did not undergo…
- Trial name
- NCT02193321
- Testing
- Amniotic Membrane Patch
- Where
- United States
- Sponsor
- University of Arizona
Atrial Fibrillation (AF), Atrial Fibrillation New Onset
Clinical Validation of SMD-AFECG for Predicting New-Onset Atrial Fibrillation Within 2 Hours Using Single-Lead ECG Data
The purpose of this retrospective study is to evaluate the clinical performance of SMD-AFECG, an artificial intelligence-based medical device software that predicts the risk of atrial fibrillation occurring within 2 hours using…
- Trial name
- NCT07722078
- Volunteers
- 797 people
- Sponsor
- HUINNO Co., Ltd
COVID-19, Atrial Fibrillation New Onset
Natural History of COVID-19-Related Atrial Fibrillation
The unCOVer-AF prospective, multicenter registry aims at determining the natural history of atrial fibrillation (AF) via continuous cardiac rhythm monitoring in patients with a first arrhythmic episode during COVID-19…
- Trial name
- unCOVer-AF (NCT04830774)
- Testing
- ILR, PMK, ICD
- Where
- 12 sites in United States, Belgium and 1 more
- Volunteers
- 200 people
- Sponsor
- Texas Cardiac Arrhythmia Research Foundation